Key result
Complete monitoring of stage 3 chronic kidney disease was performed in only 25% of patients overall, but was significantly more likely in patients with concomitant diabetes (54.9% vs 14.1%; adjusted OR 7.37).
Why the study?
Kidney Health Australia recommends regular monitoring of CKD patients to reduce progression and prevent complications, but how general practice aligns with these guidelines was unexamined.
How does clinical practice align with Kidney Health Australia's CKD monitoring guidelines in adults with stage 3 CKD?
Population
19,712 adults with laboratory evidence of stage 3 CKD in Australian general practice
Comparison
Alignment with Kidney Health Australia guideline-recommended monitoring
Design
Observational study of general practice data
Follow-up
18-month period
Authors
Loading...
CKD monitoring gaps in Australian general practice warrant quality improvement; leaves open which interventions best close adherence shortfalls.
Observational (n=19,712)
Yes
How does clinical practice align with Kidney Health Australia's CKD monitoring guidelines in adults with stage 3 CKD?
Odds Ratio: 7.37 (95% CI 6.83–7.95)
Absolute Event Rate: 54.9% vs 14.1%
p-value: p=<0.0001
Adherence to CKD monitoring guidelines in Australian general practice is low, particularly for albuminuria, highlighting a gap in preventive care.
Khanam et al. (2019) conducted an observational in Stage 3 chronic kidney disease (n=19,712). Concomitant diabetes vs. No concomitant diabetes was evaluated on Complete monitoring (at least one recorded assessment of blood pressure, urine ACR, eGFR, and serum lipids over 18 months) (OR 7.37, 95% CI 6.83-7.95, p=<0.0001). Complete monitoring of stage 3 chronic kidney disease was performed in only 25% of patients overall, but was significantly more likely in patients with concomitant diabetes (54.9% vs 14.1%; adjusted OR 7.37).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: